14201 NW 60th Avenue
Feature | Stents| May 16, 2016
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables Co
News | Cath Lab| October 09, 2015
October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiova
News | Cath Lab| August 17, 2015
The global interventional cardiology devices market is expected to reach $25.16 billion by 2020, according to a new...
Feature | March 02, 2015
Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of...
News | November 11, 2013
Researchers at Saint Luke’s Mid America Heart Institute led a ...
News | March 26, 2013
March 26, 2013 — According to two different reports from Millennium Research Group (MRG), the overall European market...
Technology | November 20, 2012
Cordis Corp. announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T. Control Vascular...
Feature | November 06, 2012 | By Dave Fornell
Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that...
Feature | August 29, 2012 | Dave Fornell
Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster...
Feature | March 29, 2012 | Dave Fornell
The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major...